Skip to main content

Advertisement

Table 2 Common aberrant regions between primary and its PDX tumor

From: Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation

GAINED REGIONS     
Chr Name Start Stop Aberration Size N° of Probes
Chr 1 794595 15755378 14960791 582
chr2 165884672 239972470 74087806 2499
chr3 132814897 195420586 62605690 1960
chr10 76385906 76844343 458439 19
chr12 322142 33190977 32868841 1192
chr15 59862504 63866586 4004083 152
chr20 60606430 62701643 2095216 123
LOST REGIONS     
Chr Name Start Stop Aberration Size N° of Probes
chr1 246042299 246655416 613118 25
chr3 18852871 32750279 13897409 382
chr4 8003753 8269985 266233 10
chr5 60785924 71460780 10674857 275
chr6 389423 26225376 25835955 858
chr7 73901713 73947170 45458 4
chr7 143425418 143432891 7474 3
chr7 153530377 153586460 56084 3
chr8 176452 22995207 22818758 751
chr8 39237438 39380654 143217 7
chr9 204193 28849141 28644949 888
chr14 63888769 105942876 42054108 1679
chr15 29212452 29253376 40925 4
chr15 34735949 34785082 49134 3
chr18 47738189 78010032 30271844 911
chr19 2936567 3027913 91347 4
chr22 23998465 24040236 41772 4